Can Dupilumab Boost Growth in Kids With Severe Eczema?
Treatment with dupilumab (Dupixent, Sanofi & Regeneron) may boost growth in kids with severe eczema, finds new research…
Study questions antihistamine use for managing eczema symptoms
Adding oral antihistamines to existing eczema treatments is unlikely to lead to clinically important reductions in eczema and itch…
Japanese study links breastfeeding to mixed risks for childhood allergies
Breastfeeding is widely recognized for its important role in supporting a child’s early growth and immune system development.…
Infrared imaging improves at-home eczema hydration monitoring
Diagnosis and management of atopic dermatitis, a type of eczema, are complicated by skin temperature fluctuations, unclear responses…
Math-based model helps optimize treatment for chronic eczema
Anyone with a chronic illness understands the struggle of living with a disease that is deeply unpredictable. Many…
Top early-life factors driving childhood food allergy
A sweeping analysis of nearly three million children pinpoints which early-life factors most strongly predict food allergy risk,…
Can introducing peanuts early prevent allergies? Real-world data confirms it helps
New evidence from a large U.S. primary care network shows that early peanut introduction, endorsed in 2015 and…
Low-calorie diets linked to higher psoriatic arthritis risk, genetic study suggests
While often promoted for health benefits, low-calorie diets may carry hidden inflammatory risks, as genetic evidence reveals a…
JAKi for Atopic Dermatitis Comparable to IL-4, IL-13 Inhibitors in Cancer, Heart Disease Risk
Sizheng Steven Zhao, MBChB, PhD Credit: University of Manchester Individuals with atopic dermatitis who initiate systemic Janus kinase…
Key Risk Factors Uncovered for AD Recurrence After Dupilumab Discontinuation
Patients who discontinue dupilumab treatment after their atopic dermatitis has cleared remain susceptible to relapse and thereby require…